Phase II clinical trial of isophosphamide (NSC-109724) in patients with advances breast cancer.

Ahmann, D L

Phase II clinical trial of isophosphamide (NSC-109724) in patients with advances breast cancer. [electronic resource] - Cancer chemotherapy reports - 861-5 p. digital

Publication Type: Clinical Trial; Journal Article

0069-0112


Antineoplastic Agents--adverse effects
Breast Neoplasms--drug therapy
Clinical Trials as Topic
Cyclic P-Oxides--adverse effects
Cyclophosphamide--adverse effects
Drug Evaluation
Drug Therapy, Combination
Ethylamines--adverse effects
Female
Fluorouracil--therapeutic use
Humans
Menopause
Middle Aged
Oxazines--adverse effects
Prednisone--therapeutic use
Vincristine--therapeutic use